Condition: Heart Transplant Rejection · Immune Suppression · Pediatric Heart Transplant · Sponsor: University of Florida
We will conduct a two-group randomized controlled trial to examine the eMocha DOT intervention with pediatric HT recipients.In this population, medication nonadherence remains a primary cause of late acute rejection (LAR) episodes, increased number of hospitalizations, graft failure, and patient mortality. Herein, we propose an innovative approach to promote medication adherence and improve patient and graft outcomes.
This description comes directly from the study's public registry record.
Dipankar Gupta, MD · 352-273-5422 · dgupta@ufl.edu
Dalia Lopez-Colon, PhD · 352-281-6723 · dalylc@ufl.edu
Always discuss trial participation with your own doctor first.
| University of Miami, Miller School of Medicine | Coral Gables, Florida, United States | Recruiting |
| University of Florida | Gainesville, Florida, United States | Recruiting |
| Joe DiMaggio Children's Hospital | Hollywood, Florida, United States | Recruiting |
| FSU College of Medicine | Tallahassee, Florida, United States | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05732779